Get the Stockscreener App
0.5799
4.18%
-0.0253
After Hours:
.46
-0.1199
-20.68%
Gritstone Bio Inc stock is traded at $0.5799, with a volume of 1.02M.
It is down -4.18% in the last 24 hours and up +21.62% over the past month.
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.
See More
Previous Close:
$0.6052
Open:
$0.5979
24h Volume:
1.02M
Relative Volume:
0.85
Market Cap:
$71.48M
Revenue:
$1.33M
Net Income/Loss:
$-138.49M
P/E Ratio:
-0.4602
EPS:
-1.26
Net Cash Flow:
$-126.22M
1W Performance:
-0.19%
1M Performance:
+21.62%
6M Performance:
-77.44%
1Y Performance:
-66.28%
1-Day Range:
$0.5734
$0.6178
1-Week Range:
$0.571
$0.6585
52-Week Range:
$0.42
$3.33
Gritstone Bio Inc Stock (GRTS) Company Profile
Name
Gritstone Bio Inc
Sector
Industry
Phone
(510) 871-6100
Address
5959 HORTON STREET, SUITE 300, EMERYVILLE, CA
Gritstone Bio Inc Stock (GRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-23 | Initiated | Evercore ISI | Outperform |
| Mar-28-23 | Initiated | B. Riley Securities | Buy |
| Oct-31-22 | Initiated | Piper Sandler | Overweight |
| Aug-22-22 | Downgrade | Goldman | Neutral → Sell |
| Dec-15-21 | Resumed | Goldman | Neutral |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Jan-20-21 | Downgrade | Robert W. Baird | Outperform → Underperform |
| Jul-26-19 | Initiated | Robert W. Baird | Outperform |
| Mar-15-19 | Initiated | Raymond James | Outperform |
| Mar-07-19 | Initiated | H.C. Wainwright | Buy |
| Oct-23-18 | Initiated | BTIG Research | Buy |
| Oct-23-18 | Initiated | Goldman | Neutral |
View All
Gritstone Bio Inc Stock (GRTS) Latest News
Gritstone bio Announces Interim Phase 2 Data for GRANITE - GlobeNewswire
Can you still get a good price for Gritstone Bio Inc (GRTS) Shares at this point? - US Post News
Gritstone Bio Inc (GRTS)’s Market Momentum: Closing Strong at 0.61, Down -0.62 - The Dwinnex
Examining the Potential Price Growth of Gritstone Bio Inc (GRTS) - Knox Daily
Gritstone bio's SWOT analysis: cancer vaccine maker's stock faces pivotal moment - Investing.com
155,915 Shares in Gritstone bio, Inc. (NASDAQ:GRTS) Bought by Point72 Asia Singapore Pte. Ltd. - Defense World
Gritstone bio, Inc. (NASDAQ:GRTS) Shares Acquired by Victory Capital Management Inc. - Defense World
Gritstone bio (NASDAQ:GRTS) Trading Down 7.4% - Defense World
Gritstone Bio Inc (GRTS) stock: A year of ups and downs - US Post News
Selling Buzz: Gritstone Bio Inc [GRTS] PRESIDENT AND CEO Allen Andrew R sells 24,263 shares of the company - Knox Daily
Stock Performance Spotlight: Gritstone Bio Inc (GRTS) Ends the Day at 0.56, Up by 0.13 - The Dwinnex
Is Gritstone Bio Inc (GRTS) positioned for future growth? - SETE News
Is Gritstone Bio Inc (GRTS) worth investing in despite its overvalued state? - US Post News
Recent Insider Activity Could Benefit Gritstone Bio Inc (GRTS) - Knox Daily
Gritstone Bio Inc (GRTS) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Piper Sandler Maintains Gritstone Bio (GRTS) Overweight Recommendation - MSN
A stock that deserves closer examination: Gritstone Bio Inc (GRTS) - US Post News
GRTS Stock Sees Decline of Approximately -5.69% in Last Five Days - Knox Daily
Gritstone bio, Inc. (NASDAQ:GRTS) Short Interest Down 8.5% in August - MarketBeat
Gritstone bio, Inc. (NASDAQ:GRTS) Stock Position Raised by Forum Financial Management LP - Defense World
Examining Gritstone Bio Inc (GRTS) more closely is necessary - US Post News
B. Riley Comments on Gritstone bio, Inc.’s FY2024 Earnings (NASDAQ:GRTS) - Defense World
Gritstone Bio Inc Inc. (GRTS) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Potential Price Increase for Gritstone Bio Inc (GRTS) After Recent Insider Activity - Knox Daily
Market Watch: Gritstone Bio Inc (GRTS)’s Noteworthy Gain, Closing at 0.50 - The Dwinnex
A company insider recently sold 24,263 shares of Gritstone Bio Inc [GRTS]. Should You Sale? - Knox Daily
Taking the lead: Gritstone Bio Inc (GRTS) - SETE News
GRTS Stock Earnings: Gritstone Bio Beats EPS, Misses Revenue for Q2 2024 - MSN
Gritstone bio Inc. (GRTS) Reports Q2 Loss, Misses Revenue Estimates - MSN
Gritstone Bio Inc [GRTS] Insider Activity: An Update for Investors - Knox Daily
GRTS (Gritstone Bio Inc) has impressive results - US Post News
Q3 2024 EPS Estimates for Gritstone bio, Inc. Lifted by Analyst (NASDAQ:GRTS) - MarketBeat
Financial Metrics Unveiled: Gritstone Bio Inc (GRTS)’s Key Ratios in the Spotlight - The Dwinnex
Analyzing Moderna (NASDAQ:MRNA) & Gritstone bio (NASDAQ:GRTS) - Defense World
HC Wainwright Comments on Gritstone bio, Inc.’s Q3 2024 Earnings (NASDAQ:GRTS) - Defense World
Gritstone Bio (FRA:2JQ) Enterprise Value : €96.47 Mil (As of Aug. 19, 2024) - GuruFocus.com
Gritstone bio (NASDAQ:GRTS) Rating Reiterated by HC Wainwright - Defense World
GRTS Shares Experience Surge in Value - Knox Daily
There is no doubt that Gritstone Bio Inc (GRTS) ticks all the boxes. - SETE News
Gritstone bio Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Gritstone bio, Inc. Sued for Securities Law ViolationsContact The Rosen Law Firm Before August 6, 2024 to Discuss Your Rights - Longview News-Journal
HC Wainwright Reiterates Buy Rating for Gritstone bio (NASDAQ:GRTS) - MarketBeat
Gritstone bio (NASDAQ:GRTS) Issues Earnings Results, Beats Estimates By $0.12 EPS - Defense World
Gritstone bio, Inc. Sued for Securities Law ViolationsContact The Rosen Law Firm Before August 6, 2024 to Discuss Your RightsGRTS - Longview News-Journal
Gritstone Bio Inc Inc. (GRTS) Price Performance: A Technical Analysis Perspective - The InvestChronicle
TD Cowen keeps Buy rating on Gritstone bio shares By Investing.com - Investing.com UK
GRTS Investors Have Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit - Longview News-Journal
Gritstone bio (NASDAQ:GRTS) Releases Quarterly Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat
Gritstone bio, Inc. (NASDAQ:GRTS) Shares Bought by Vanguard Group Inc. - Defense World
Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - BioSpace
GRTS Stock Earnings: Gritstone Bio Beats EPS, Misses Revenue for Q2 2024 - InvestorPlace
Gritstone Bio Inc Stock (GRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):